|
1
|
Kim MJ, Won JK, Jung KC, Kim JH, Cho SW,
Park DJ and Park YJ: Clinical characteristics of subtypes of
follicular variant papillary thyroid carcinoma. Thyroid.
28:311–318. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sipos JA and Mazzaferri EL: Thyroid cancer
epidemiology and prognostic variables. Clin Oncol (R Coll Radiol).
22:395–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng R, Zeng H, Zhang S and Chen W:
Estimates of cancer incidence and mortality in China, 2013. Chin J
Cancer. 36:662017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmidbauer B, Menhart K, Hellwig D and
Grosse J: Differentiated thyroid cancer-treatment: State of the
art. Int J Mol Sci. 18(pii): E12922017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nasef HO, Nixon IJ and Wreesmann VB:
Optimization of the risk-benefit ratio of differentiated thyroid
cancer treatment. Eur J Surg Oncol. 44:276–285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chmielik E, Rusinek D, Oczko-Wojciechowska
M, Jarzab M, Krajewska J, Czarniecka A and Jarzab B: Heterogeneity
of thyroid cancer. Pathobiology. 85:117–129. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kato H, Morioka H, Aramaki S and Torigoe
T: Radioimmunoassay for tumor-antigen of human cervical squamous
cell carcinoma. Cell Mol Biol Incl Cyto Enzymol. 25:51–56.
1979.PubMed/NCBI
|
|
8
|
Schneider SS, Schick C, Fish KE, Miller E,
Pena JC, Treter SD, Hui SM and Silverman GA: A serine proteinase
inhibitor locus at 18q21.3 contains a tandem duplication of the
human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA.
92:3147–3151. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vassilakopoulos T, Troupis T, Sotiropoulou
C, Zacharatos P, Katsaounou P, Parthenis D, Noussia O, Troupis G,
Papiris S, Kittas C, et al: Diagnostic and prognostic significance
of squamous cell carcinoma antigen in non-small cell lung cancer.
Lung Cancer. 32:137–144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guido M, Roskams T, Pontisso P, Fassan M,
Thung SN, Giacomelli L, Sergio A, Farinati F, Cillo U and Rugge M:
Squamous cell carcinoma antigen in human liver carcinogenesis. J
Clin Pathol. 61:445–447. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Catanzaro JM, Guerriero JL, Liu J, Ullman
E, Sheshadri N, Chen JJ and Zong WX: Elevated expression of
squamous cell carcinoma antigen (SCCA) is associated with human
breast carcinoma. PLoS One. 6:e190962011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pontisso P: Role of SERPINB3 in
hepatocellular carcinoma. Ann Hepatol. 13:722–727. 2014.PubMed/NCBI
|
|
13
|
Zhao W, Yu H, Han Z, Gao N, Xue J and Wang
Y: Clinical significance of joint detection of serum CEA, SCCA, and
bFGF in the diagnosis of lung cancer. Int J Clin Exp Pathol.
8:9506–9511. 2015.PubMed/NCBI
|
|
14
|
Deng Z, Hasegawa M, Yamashita Y, Matayoshi
S, Kiyuna A, Agena S, Uehara T, Maeda H and Suzuki M: Prognostic
value of human papillomavirus and squamous cell carcinoma antigen
in head and neck squamous cell carcinoma. Cancer Sci.
103:2127–2134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng X, Xing S, Liu XM, Liu W, Liu D, Chi
PD, Chen H, Dai SQ, Zhong Q, Zeng MS, et al: Establishment of using
serum YKL-40 and SCCA in combination for the diagnosis of patients
with esophageal squamous cell carcinoma. BMC Cancer. 14:4902014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guarino M, Di Costanzo GG, Gallotta A,
Tortora R, Paneghetti L, Auriemma F, Tuccillo C, Fassina G,
Caporaso N and Morisco F: Circulating SCCA-IgM complex is a useful
biomarker to predict the outcome of therapy in hepatocellular
carcinoma patients. Scand J Clin Lab Invest. 77:448–453. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Wang X, He H, Liu Z, Hu JF and Li
W: Combination of circulating tumor cells with serum
carcinoembryonic antigen enhances clinical prediction of non-small
cell lung cancer. PLoS One. 10:e01262762015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brioschi PA, Bischof P, Delafosse C and
Krauer F: Squamous-cell carcinoma antigen (SCC-A) values related to
clinical outcome of pre-invasive and invasive cervical carcinoma.
Int J Cancer. 47:376–379. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao L, Wang X, Li S, Zhi Q, Wang Y, Wang
L, Li K and Jiang R: PD-L1 is a prognostic biomarker in resected
NSCLC patients with moderate/high smoking history and elevated
serum SCCA level. J Cancer. 8:3251–3260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Downward J: Targeting RAS signalling
pathways in cancer therapy. Nature Rev Cancer. 3:11–22. 2003.
View Article : Google Scholar
|
|
21
|
Schmukler E, Kloog Y and Pinkas-Kramarski
R: Ras and autophagy in cancer development and therapy. Oncotarget.
5:577–586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ye K, Li J, Li X, Chang S and Zhang Z:
Ang1/Tie2 induces cell proliferation and migration in human
papillary thyroid carcinoma via the PI3K/AKT pathway. Oncol Lett.
15:1313–1318. 2018.PubMed/NCBI
|
|
23
|
Pylayeva-Gupta Y, Grabocka E and Bar-Sagi
D: RAS oncogenes: Weaving a tumorigenic web. Nature Rev Cancer.
11:761–774. 2011. View Article : Google Scholar
|
|
24
|
Cox AD and Der CJ: Ras history: The saga
continues. Small GTPases. 1:2–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Frodyma D, Neilsen B, Costanzo-Garvey D,
Fisher K and Lewis R: Coordinating ERK signaling via the molecular
scaffold Kinase Suppressor of Ras. F1000Res. 6:16212017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eser S, Schnieke A, Schneider G and Saur
D: Oncogenic KRAS signalling in pancreatic cancer. Br J Cancer.
111:817–822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Margonis GA, Kim Y, Sasaki K, Samaha M,
Amini N and Pawlik TM: Codon 13 KRAS mutation predicts patterns of
recurrence in patients undergoing hepatectomy for colorectal liver
metastases. Cancer. 122:2698–2707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Christensen TD, Palshof JA, Larsen FO,
Poulsen TS, Høgdall E, Pfeiffer P, Jensen BV, Yilmaz MK and Nielsen
D: Associations between primary tumor RASBRAFPIK3CA mutation
status and metastatic site in patients with chemo-resistant
metastatic colorectal cancer. Acta Oncol. 57:1057–1062. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zaballos MA and Santisteban P: Key
signaling pathways in thyroid cancer. J Endocrinol. 235:R43–R61.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang J, Cai W, Feng D, Teng H, Mao F,
Jiang Y, Hu S, Li X, Zhang Y, Liu B and Sun ZS: Genetic landscape
of papillary thyroid carcinoma in the Chinese population. J Pathol.
244:215–226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sanclemente M, Francoz S, Esteban-Burgos
L, Bousquet-Mur E, Djurec M, Lopez-Casas PP, Hidalgo M, Guerra C,
Drosten M, Musteanu M, et al: c-RAF ablation induces regression of
advanced Kras/Trp53 mutant lung adenocarcinomas by a
mechanism independent of MAPK signaling. Cancer cell. 33:217–228.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xing M: Genetic alterations in the
phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.
Thyroid. 20:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ning L, Rao W, Yu Y, Liu X, Pan Y, Ma Y,
Liu R, Zhang S, Sun H and Yu Q: Association between the KRAS
gene polymorphisms and papillary thyroid carcinoma in a Chinese Han
population. J Cancer. 7:2420–2426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Catanzaro JM, Sheshadri N, Pan JA, Sun Y,
Shi C, Li J, Powers RS, Crawford HC and Zong WX: Oncogenic Ras
induces inflammatory cytokine production by upregulating the
squamous cell carcinoma antigens SerpinB3/B4. Nat Commun.
5:37292014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luo D, Chen H, Li X, Lu P, Long M, Peng X,
Lin S, Tan L, Zhu Y, Ouyang N, et al: Activation of the ROCK1/MMP-9
pathway is associated with the invasion and poor prognosis in
papillary thyroid carcinoma. Int J Oncol. 51:1209–1218. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM,
Schlumberger M, et al: 2015 Αmerican thyroid association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The american thyroid association
guidelines task force on thyroid nodules and differentiated thyroid
cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ming J, Liu Z, Zeng W, Maimaiti Y, Guo Y,
Nie X, Chen C, Zhao X, Shi L, Liu C, et al: Association between
BRAFRAS mutations, and RET rearrangements and the
clinical features of papillary thyroid cancer. Int J Clin Exp
Pathol. 8:15155–15162. 2015.PubMed/NCBI
|
|
39
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han X, Wen H, Ju X, Chen X, Ke G, Zhou Y,
Li J, Xia L, Tang J, Liang S, et al: Predictive factors of
para-aortic lymph nodes metastasis in cervical cancer patients: A
retrospective analysis based on 723 para-aortic lymphadenectomy
cases. Oncotarget. 8:51840–51847. 2017.PubMed/NCBI
|
|
41
|
Markovina S, Wang S, Henke LE, Luke CJ,
Pak SC, DeWees T, Pfeifer JD, Schwarz JK, Liu W, Chen S, et al:
Serum squamous cell carcinoma antigen as an early indicator of
response during therapy of cervical cancer. Br J Cancer. 118:72–78.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fassan M, Realdon S, Vianello L, Quarta S,
Ruol A, Castoro C, Scarpa M, Zaninotto G, Guzzardo V, Chiarion
Sileni V, et al: Squamous cell carcinoma antigen (SCCA) is
up-regulated during Barrett's carcinogenesis and predicts
esophageal adenocarcinoma resistance to neoadjuvant chemotherapy.
Oncotarget. 8:24372–24379. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sheshadri N, Catanzaro JM, Bott AJ, Sun Y,
Ullman E, Chen EI, Pan JA, Wu S, Crawford HC, Zhang J, et al:
SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal
transition via the unfolded protein response and IL6 signaling.
Cancer Res. 74:6318–6329. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang L, Zheng M, Liu JH, Xiong Y, Ding H,
Tang L and Wang HY: Risk factors and prognosis of IB-IIB cervical
carcinoma with common iliac lymph node metastasis. Chin J Cancer.
29:431–435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Aoki Y, Sasaki M, Watanabe M, Sato T,
Tsuneki I, Aida H and Tanaka K: High-risk group in node-positive
patients with stage IB IIA, and IIB cervical carcinoma after
radical hysterectomy and postoperative pelvic irradiation. Gynecol
Oncol. 77:305–309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yoon SM, Shin KH, Kim JY, Seo SS, Park SY,
Moon SH and Cho KH: Use of serum squamous cell carcinoma antigen
for follow-up monitoring of cervical cancer patients who were
treated by concurrent chemoradiotherapy. Radiat Oncol. 5:782010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tripathi K and Garg M: Mechanistic
regulation of epithelial-to-mesenchymal transition through RAS
signaling pathway and therapeutic implications in human cancer. J
Cell Commun Signal. 12:513–527. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jeong SH, Hong HS, Kwak JJ and Lee EH:
Analysis of RAS mutation and PAX8/PPARg rearrangements in
follicular-derived thyroid neoplasms in a Korean population:
Frequency and ultrasound findings. J Endocrinol Invest. 38:849–857.
2015. View Article : Google Scholar : PubMed/NCBI
|
